Steven Allen Lewis, MS, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 800 Leslie St, Nashville, AR 71852 Phone: 870-845-8161 |
Candice Rochelle Jefferson, PT,DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 132 Medical Cir Ste 300, Nashville, AR 71852 Phone: 870-845-8161 |
Barbara A. Segovis, P.T. Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 22 Southpark Shopping Ctr, Nashville, AR 71852 Phone: 870-845-5600 Fax: 870-845-5605 |
Mr. Darin Tollett, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 130 Medical Cir, Nashville, AR 71852 Phone: 870-845-8161 Fax: 870-845-8284 |
Calista E. Snow, P.T. Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 22 Southpark Shopping Ctr, Nashville, AR 71852 Phone: 870-845-5600 Fax: 870-845-5605 |
Brittanee Hankins, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 132 Medical Cir Ste 300, Nashville, AR 71852 Phone: 870-845-8161 Fax: 870-845-8284 |
Rehab Specialists, Inc. Physical Therapist Medicare: Medicare Enrolled Practice Location: 500 Musgrave, Nashville, AR 71852 Phone: 870-845-5600 Fax: 870-845-5605 |
Mr. Paul S Cox, PT Physical Therapist Medicare: Medicare Enrolled Practice Location: 800 Leslie St, Nashville, AR 71852 Phone: 870-845-8161 |
News Archive
Boehringer Ingelheim today announced the initiation of two phase II studies, 1200.89 and LUX-Breast 2, evaluating afatinib in patients with metastatic breast cancer, who have an overexpression of the erbB2 (HER2) protein, so called HER2-positive patients. Afatinib is an irreversible ErbB Family Blocker, which binds to all erbB-family kinases including erbB2.
The Institute of Food Research has collaborated in the development of a new method for detecting spores of non-proteolytic Clostridium botulinum. This bacterium is the major health hazard associated with refrigerated convenience foods, and these developments give the food industry and regulators more quantitative information on which to base the procedures that ensure food safety.
Genentech, a member of the Roche Group, announced today interim clinical data from the dose-finding parts of the pivotal FIREFISH and SUNFISH studies investigating risdiplam in spinal muscular atrophy.
Heart transplant recipients and their physicians are likely more concerned with the function of the donated organ than with the donor's DNA sequences that tag along in the new, healthy tissue.
› Verified 7 days ago